Join the DDA or

PCCA ketamine solution recall

Nine affected batches

June 16th 2022

Tagged: MHRA alert

By MHRA

PCCA Limited is recalling six batches of  Ketamine 50mg in 5ml oral solution (unlicensed medicine) and three batches of Ketamine 100mg in 5ml oral solution (unlicensed medicine).

The affected batches are as follows:

Batch NumberExpiry DatePack SizeFirst Distributed
15806-7507-July-2022300ml08-April-2022
15806-7618-July-2022200ml19-April-2022
15806-7707-August-2022100ml09-May-2022
15806-7814-August-2022200ml16-May-2022
15806-7914-August-2022200ml16-May-2022
15806-8017-August-2022100ml19-May-2022

Ketamine 100mg in 5ml Oral Solution (unlicensed medicine)

Batch NumberExpiry DatePack SizeFirst Distributed
18640-2026-June-2022100ml28-Mar-2022
18640-2124-July-2022100ml25-Apr-2022
18640-2217-August-2022100ml19-May-2022

The recall is precautionary due to the appearance of crystalline material and healthcare teams should quarantine affected stock and return to the company.  Patients should be contacted to return affected product to their GP.

For medical information enquiries, please email: [email protected]

For stock information enquiries, please email: [email protected]